Snapshot from Aug 23, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Gland Pharma Neuland sterile API...
Business CDMO partnership

Gland Pharma Neuland sterile API CDMO partnership

Analysis based on 9 articles · First reported Aug 05, 2026 · Last updated Aug 05, 2026

Sentiment
15
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The partnership is expected to enhance both companies' positions in the growing sterile API CDMO market, potentially boosting revenue and capacity utilization. Gland Pharma's expansion of sterile manufacturing capabilities and Neuland's access to dedicated capacity could positively impact their financial performance and stock valuations.

Pharmaceuticals Contract manufacturing
Event Summary

Gland Pharma and Abbott Laboratories announced a long-term strategic CDMO partnership to expand sterile active pharmaceutical ingredient (API) manufacturing. Under the agreement, Gland Pharma will build a dedicated sterile manufacturing suite at its JNPC facility in Visakhapatnam, India, to support Neuland's growing demand for sterile APIs used in microparticle depot products and other complex sterile APIs. The suite will be constructed and operated to cGMP, USFDA, and EU standards, adding approximately 1,400 kg of annual capacity. The collaboration combines Neuland's complex API development and manufacturing capabilities with Gland Pharma's global sterile manufacturing expertise, offering an integrated CDMO solution covering development, scale-up, regulatory support, and commercial manufacturing. The partnership aims to strengthen global supply resilience for innovators and generic drugmakers. Neuland's board approved a corporate guarantee of ₹40 crore in favor of Gland Pharma. Executives Srinivas Sadu (Gland Pharma) and Saharsh Davuluri (Neuland) highlighted the strategic benefits of the collaboration.

Key Actions
100 Gland Pharma entered partnership Abbott Laboratories
80 Abbott Laboratories approved corporate guarantee Gland Pharma
Entities Involved
stock
Gland Pharma
Gland Pharma is a key partner, expanding its sterile manufacturing infrastructure with a new suite at Visakhapatnam, adding 1,400 kg annual capacity. This strengthens its CDMO offerings and may drive future revenue growth.
Importance 100.0 Sentiment 20.0
stock
Abbott Laboratories
Neuland gains dedicated sterile API manufacturing capacity through Gland Pharma, supporting its growing demand and enhancing its CDMO capabilities. The corporate guarantee of ₹40 crore reflects its commitment.
Importance 100.0 Sentiment 20.0
cnt
India
The partnership strengthens India's pharmaceutical manufacturing capabilities, with both companies based in Hyderabad and the new facility in Visakhapatnam, contributing to the country's position as a global pharma hub.
Importance 30.0 Sentiment 10.0
per
Srinivas Sadu
As Executive Chairman of Gland Pharma, Srinivas Sadu announced the partnership, highlighting its strategic value in expanding sterile API capabilities and meeting customer demand.
Importance 30.0 Sentiment 10.0
per
Saharsh Davuluri
As CEO & MD of Abbott Laboratories, Saharsh Davuluri emphasized the collaboration's role in delivering quality and supply assurance to global customers, reinforcing Neuland's market position.
Importance 30.0 Sentiment 10.0
govactor
United States — Food and Drug Administration
The new facility will be built to USFDA standards, ensuring regulatory compliance for the US market, which is critical for the partnership's success.
Importance 20.0 Sentiment 0.0
alliance
European Union
The facility will also meet EU standards, enabling access to European markets and enhancing the partnership's global reach.
Importance 20.0 Sentiment 0.0
Relationships
Abbott Laboratories related ↔ India
Abbott Laboratories related ↔ United States — Food and Drug Administration
India related ↔ United States — Food and Drug Administration
India related ↔ European Union
United States — Food and Drug Administration related ↔ European Union
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.